Anticoagulation: Better treatment option than PFO closure or antiplatelet?
A review of the clinical evidence of anticoagulation in comparison to PFO closure and antiplatelet therapy to reduce recurrent stroke risk in cryptogenic stroke patients.
Gore REDUCE Clinical Study sub-analysis summary
Learn about the types and severity of recurrent strokes in the Gore REDUCE Clinical Study arms as published in the Journal of American College of Cardiology.
Is your stroke patient a candidate for PFO closure?
Learn key points to consider when evaluating cryptogenic stroke patients and how to utilize the RoPE score to determine if PFO closure should be considered.
This information is intended for education and awareness only. Patients should consult their physician for information on the risks associated with the devices and surgical procedures discussed in this website. All surgical procedures carry potential health risks. Not all patients will be candidates for treatment with these devices, and individual outcomes may vary.
Always follow physician advice on your post-surgery care and recovery.
Refer to the Instructions for Use for a complete list of warnings, precautions, contraindications, potential adverse events and patient-specific information.
Caution: U.S. law restricts use of this device on the order of a physician (Rx).
APPLE is a trademark of Apple, Inc.